Login / Signup

Engineered NLS-chimera downregulates expression of aggregation-prone endogenous FUS.

Miyuki HayashiAmandeep GirdharYing-Hui KoKevin M KimJacquelyn A DePierroJoseph R BuchlerNikhita ArunprakashAditya BajajGino CingolaniLin Guo
Published in: Nature communications (2024)
Importin β-superfamily nuclear import receptors (NIRs) mitigate mislocalization and aggregation of RNA-binding proteins (RBPs), like FUS and TDP-43, which are implicated in neurodegenerative diseases. NIRs potently disaggregate RBPs by recognizing their nuclear localization signal (NLS). However, disease-causing mutations in NLS compromise NIR binding and activity. Here, we define features that characterize the anti-aggregation activity of NIR and NLS. We find that high binding affinity between NIR and NLS, and optimal NLS location relative to the aggregating domain plays a role in determining NIR disaggregation activity. A designed FUS chimera (FUS IBB ), carrying the importin β binding (IBB) domain, is solubilized by importin β in vitro, translocated to the nucleus in cultured cells, and downregulates the expression of endogenous FUS. In this study, we posit that guiding the mutual recognition of NLSs and NIRs will aid the development of therapeutics, illustrated by the highly soluble FUS IBB replacing the aggregation-prone endogenous FUS.
Keyphrases